The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Tumoral and tissue‐specific expression of the major human β‐tubulin isotypes
Abstract
The β‐tubulins are microtubule components encoded by a multigene family, which produces slightly different proteins with complex expression patterns. Several widely used anticancer drugs base their activity on β‐tubulin binding, microtubule dynamics alteration, and cell division blockage. The expression of these drug targets in tumoral and normal cells could be of crucial importance for therapy outcome, unfortunately, the complex β‐tubulin expression patterns have been poorly characterized in human. In this study, we developed a quantitative RT‐PCR technique that accurately determines the mRNA expression of the eight human β‐tubulin isotypes, encoding class I, IIa, IIb, III, IVa, IVb, V, and VI and applied it to 21 nontumoral tissues and 79 tumor samples belonging to seven cancer types. In the nontumoral tissues, we found that, overall, TUBB (I), TUBB2C (IVb), and TUBB6 (V) were ubiquitous, TUBB1(VI) was hematopoietic cell‐specific, and TUBB2A (IIa), TUBB2B (IIb), TUBB3 (III), and TUBB4 (IVa) had high expression in brain; however, the contribution of the different isotypes to the total β‐tubulin content varied for each tissue and had a complex pattern. In tumoral tissues, most isotypes exhibited an altered expression in specific tumor types or related to tumoral characteristics. In general, TUBB3 showed a great increase in expression while TUBB6 expression was largely decreased in most tumors. Thus, normal tissues showed a complex β‐tubulin isotype distribution, which could contribute to the toxicity profile of the microtubule‐binding drugs. In addition, the specific isotypes significantly altered in tumors might represent markers for drug response. © 2010 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Quantification on the LightCycler
Rasmussen, R. (2001) · Rapid Cycle Real-Time PCR · doi:10.1007/978-3-642-59524-0_3 · Cited by 892
Berry, D. A., Cirrincione, C., Henderson, I. C., Citron, M. L., Budman, D. R., Goldstein, L. J., Martino, S., Perez, E. A., Muss, H. B., Norton, L., et al. (2006) · JAMA · doi:10.1001/jama.295.14.1658 · Cited by 731
Giannakakou, P., Sackett, D. L., Kang, Y.-K., Zhan, Z., Buters, J. T. M., Fojo, T., & Poruchynsky, M. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17118 · Cited by 681
Multiple Forms of Tubulin: Different Gene Products and Covalent Modifications
Ludueña, R. F. (1997) · International Review of Cytology · doi:10.1016/s0074-7696(08)62138-5 · Cited by 611
Verhey, K. J., & Gaertig, J. (2007) · Cell Cycle · doi:10.4161/cc.6.17.4633 · Cited by 558
Giannakakou, P., Gussio, R., Nogales, E., Downing, K. H., Zaharevitz, D., Bollbuck, B., Poy, G., Sackett, D., Nicolaou, K. C., & Fojo, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040546297 · Cited by 477
Sullivan, K. F., & Cleveland, D. W. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4327 · Cited by 400
Microtubule dynamics in vitro are regulated by the tubulin isotype composition.
Panda, D., Miller, H. P., Banerjee, A., Ludueña, R. F., & Wilson, L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11358 · Cited by 374
Mozzetti, S., Ferlini, C., Concolino, P., Filippetti, F., Raspaglio, G., Prislei, S., Gallo, D., Martinelli, E., Ranelletti, F. O., Ferrandina, G., et al. (2005) · PubMed · Cited by 323
Mozzetti, S., Ferlini, C., Concolino, P., Filippetti, F., Raspaglio, G., Prislei, S., Gallo, D., Martinelli, E., Ranelletti, F. O., Ferrandina, G., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.298.11.1 · Cited by 303
Wang, D., Villasante, A., Lewis, S. A., & Cowan, N. J. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.5.1903 · Cited by 279
Derry, W. B., Wilson, L., Khan, I. A., Ludueña, R. F., & Jordan, M. A. (1997) · Biochemistry · doi:10.1021/bi962724m · Cited by 252
Microtubule dynamics as a target in oncology
Risinger, A. L., Giles, F. J., & Mooberry, S. L. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.11.001 · Cited by 248
Kamath, K., Wilson, L., Cabral, F., & Jordan, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414477200 · Cited by 247
Lopata, M. A., & Cleveland, D. W. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.4.1707 · Cited by 232
Kavallaris, M., Tait, A., Walsh, B. J., He, L., Horwitz, S. B., Norris, M. D., & Haber, M. (2001) · PubMed · Cited by 221
Ferrandina, G., Zannoni, G. F., Martinelli, E., Paglia, A., Gallotta, V., Mozzetti, S., Scambia, G., & Ferlini, C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2715 · Cited by 219
Increased microtubule assembly in bovine brain tubulin lacking the type III isotype of beta-tubulin.
Banerjee, A., Roach, M. C., Trcka, P., & Ludueña, R. F. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40087-2 · Cited by 218
The multitubulin hypothesis revisited: what have we learned?
Cleveland, D. W. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.3.381 · Cited by 214
Do β-tubulin mutations have a role in resistance to chemotherapy?
Berrieman, H. K., Lind, M., & Cawkwell, L. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01411-1 · Cited by 153
Expression of class III β‐tubulin reduces microtubule assembly and confers resistance to paclitaxel
Hari, M., Yang, H., Zeng, C., Canizales, M., & Cabral, F. (2003) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.10132 · Cited by 148
Hasegawa, S., Miyoshi, Y., Egawa, C., Ishitobi, M., Taguchi, T., Tamaki, Y., Monden, M., & Noguchi, S. (2003) · PubMed · Cited by 113
Microtubule Alterations and Mutations Induced by Desoxyepothilone B
Verrills, N. M., Flemming, C. L., Liu, M., Ivery, M. T. G., Cobon, G. S., Norris, M. D., Haber, M., & Kavallaris, M. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00141-8 · Cited by 108
Alterations of β‐tubulin isotypes in breast cancer cells resistant to docetaxel
Shalli, K., Brown, I. M., Heys, S. D., & Schofield, C. A. (2005) · The FASEB Journal · doi:10.1096/fj.04-3178fje · Cited by 107
A Ubiquitous β-tubulin Disrupts Microtubule Assembly and Inhibits Cell Proliferation
Bhattacharya, R., & Cabral, F. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-01-0060 · Cited by 95
Conforti, R., Boulet, T., Tomasic, G., Clermont, E., Arriagada, R., Spielmann, M., Ducourtieux, M., Soria, J., Tursz, T., Delaloge, S., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm209 · Cited by 88
Nicoletti, M. I., Valoti, G., Giannakakou, P., Zhan, Z., Kim, J. H., Lucchini, V., Landoni, F., Mayo, J. G., Giavazzi, R., & Fojo, T. (2001) · PubMed · Cited by 85
Blade, K. L., Menick, D. R., & Cabral, F. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.13.2213 · Cited by 75
Sullivan, K. F., Havercroft, J. C., Machlin, P. S., & Cleveland, D. W. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.12.4409-4418.1986 · Cited by 62
Conformational Analysis of the Carboxy-Terminal Tails of Human β-Tubulin Isotypes
Luchko, T., Huzil, J. T., Stepanova, M., & Tuszyński, J. A. (2007) · Biophysical Journal · doi:10.1529/biophysj.107.115113 · Cited by 61
Gan, P. P., & Kavallaris, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1501 · Cited by 59
André, F., Broglio, K. R., Roche, H. H., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.9146 · Cited by 59
Cited by
Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression
Selamat, S. A., Chung, B. S., Girard, L., Zhang, W., Zhang, Y., Campan, M., Siegmund, K. D., Koss, M. N., Hagen, J. A., Lam, W. L., et al. (2012) · Genome Research · doi:10.1101/gr.132662.111 · Cited by 521
Liang, Z.-X., Liu, H.-S., Wang, F.-W., Xiong, L., Zhou, C., Hu, T., He, X.-W., Wu, X.-J., Xie, D., Wu, X.-R., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2077-0 · Cited by 361
Therapeutic strategies to overcome taxane resistance in cancer
Das, T., Anand, U., Pandey, S. K., Ashby, C. R., Assaraf, Y. G., Chen, Z.-S., & Dey, A. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100754 · Cited by 253
Al-Khafaji, A. S. K., Marcus, M. W., Davies, M. P. A., Risk, J. M., Shaw, R. J., Field, J. K., & Liloglou, T. (2017) · Oncology Letters · doi:10.3892/ol.2017.6012 · Cited by 51
Metadata
- Authors
- Leandro‐García, L. J., Leskelä, S., Landa, I., Montero‐Conde, C., López‐Jiménez, E., Letón, R., Cascón, A., Robledo, M., & Rodríguez‐Antona, C.
- Venue
- Cytoskeleton
- Publisher
- Wiley
- Published
- 2010-03-04
- Volume
- 67
- Issue
- 4
- Pages
- 214-223
- ISSN
- 1949-3584 (ISSN-L)
- 1949-3592
- OpenAlex
- W2135726973
- Cited by
- 265
- References
- 33
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.